Lv1
50 积分 2025-04-29 加入
Reply to: “Re: Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials”
1天前
求助中
Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial
4天前
已完结
Paclitaxel-Releasing Balloon in Femoropopliteal Lesions Using a BTHC Excipient
4天前
已完结
Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial
6天前
已关闭
Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study
7天前
已完结
Orchid drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of femoropopliteal artery disease: 12-month result of the randomized controlled trial
7天前
已完结
No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes
7天前
已完结
Long-term follow up and mortality rate of patients of the randomized Freeway Stent Study
7天前
已完结
Factors Associated With Early and Late Restenosis Following Drug-Coated Balloon Treatment for Patients With Femoropopliteal Lesions
7天前
已完结
Contemporary Therapy of Femoropopliteal In-Stent Restenosis / Occlusion, 36-month Follow up Study
9天前
已完结
皖公网安备34019202002308
